Evolution of Virulence in Emerging Epidemics

PLoS Pathogens

Volumn 9, Issue 3, 2013, Pages

  Berngruber, Thomas W ^a   Froissart, Rémy ^b,c   Choisy, Marc ^c,d   Gandon, Sylvain ^a  

^a CENTRE D ECOLOGIE FONCTIONNELLE ET EVOLUTIVE   (France)

^b Campus International de Baillarguet   (France)

^c University de Montpellier   (France)

^d OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; BACTERIOPHAGE LAMBDA; CHEMOSTAT; CONTROLLED STUDY; DISEASE TRANSMISSION; ESCHERICHIA COLI; EVOLUTION; FLOW CYTOMETRY; INFECTION; LATENT VIRUS INFECTION; MORTALITY; MUTANT; NONHUMAN; POLYMERASE CHAIN REACTION; PROVIRUS; BIOLOGICAL MODEL; COMMUNICABLE DISEASES, EMERGING; ENTEROBACTERIA PHAGE LAMBDA; EPIDEMIC; HOST PATHOGEN INTERACTION; MUTATION; PATHOGENICITY; TRANSMISSION; VIROLOGY; VIRULENCE;

ENTEROBACTERIA PHAGE LAMBDA; ESCHERICHIA COLI;

BACTERIOPHAGE LAMBDA; BIOLOGICAL EVOLUTION; COMMUNICABLE DISEASES, EMERGING; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMICS; ESCHERICHIA COLI; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; MODELS, BIOLOGICAL; MUTATION; VIRULENCE;

EID: 84876004191     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003209     Document Type: Article

References (45)

1. Frank SA, (1996) Models of parasite virulence. Q Rev Biol 71: 37-78.
2. Dieckmann U, Metz JAJ, Sabelis MW, Sigmund K (2002) Adaptive dynamics of infectious diseases: in pursuit of virulence management. Cambridge: Cambridge University Press. 532 p.
3. Yoshida T, Jones LE, Ellner SP, Fussmann GF, Hairston Jr. NG, (2003) Rapid evolution drives ecological dynamics in a predator-prey system. Nature 424: 303-306.
4. Hairston NG, Ellner SP, Geber MA, Yoshida T, Fox JA, (2005) Rapid evolution and the convergence of ecological and evolutionary time. Ecology Letters 8: 1114-1127.
5. Bull JJ, Millstein J, Orcutt J, Wichman HA, (2006) Evolutionary feedback mediated through population density, illustrated with viruses in chemostats. Am. Nat 167: E39-E51.
6. Arista S, Giammanco GM, De Grazia S, Ramirez S, Lo Biundo C, et al. (2006) Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population. J Virol 80: 10724-10733.
7. Gallimore CI, Iturriza-Gomara M, Xerry J, Adigwe J, Gray JJ, (2007) Inter-seasonal diversity of norovirus genotypes: Emergence and selection of virus variants. Arch Virol 152: 1295-1303.
8. Ojosnegros S, Beerenwinkel N, Antal T, Nowak MA, Escarmis C, et al. (2010) Competition-colonization dynamics in an RNA virus. Proc Natl Acad Sci USA 107: 2108-2112.
9. Wright CF, Morelli MJ, Thébaud G, Knowles NJ, Herzyk P, et al. (2011) Beyond the consensus: Dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. J Virol 85: 2266-2275.
10. Vijaykrishna D, Smith GJ, Pybus OG, Zhu H, Bhatt S, et al. (2011) Long-term evolution and transmission dynamics of swine influenza A virus. Nature 473: 519-522.
11. Lenski RE, May RM, (1994) The evolution of virulence in parasites and pathogens: Reconciliation between two competing hypotheses. J Theor Biol 169: 253-265.
12. Day T, Gandon S, (2007) Applying population-genetic models in theoretical evolutionary epidemiology. Ecol Lett 10: 876-888.
13. Bull JJ, Ebert D, (2008) Invasion thresholds and the evolution of nonequilibrium virulence. Evol Appl 1: 172-182.
14. Bolker BM, Nanda A, Shah D, (2010) Transient virulence of emerging pathogens. J R Soc Interface 7: 811-822.
15. Stewart FM, Levin BR, (1984) The population biology of bacterial viruses: why be temperate. Theor Popul Biol 26: 93-117.
16. Day T, Proulx SR, (2004) A General Theory for the Evolutionary Dynamics of Virulence. Am. Nat 163: E40-E63.
17. Day T, Gandon S. (2006) Insights from Price's equation into evolutionary epidemiology. In: Feng Z Dieckmann U, Levin S, editors. Disease evolution: models, concepts and data analyses. The American Mathematical Society.
18. Gandon S, Day T, (2007) The evolutionary epidemiology of vaccination. J R Soc Interface 4: 803-817.
19. Dykhuizen DE, Dean AM. (2009) Experimental Evolution from the Bottom Up. In: Garland T, Rose MR editors. Experimental Evolution: Concepts, Methods, and Applications of Selection Experiments. Berkley: University of California Press.
20. Ptashne M. (1992) A Genetic Switch: Phage Lambda and Higher Organisms. Oxford: Blackwell Publishers.
21. St-Pierre F, Endy D, (2008) Determination of cell fate selection during phage lambda infection. Proc Natl Acad Sci USA 105: 20705-20710.
22. Zeng L, Skinner SO, Zong C, Sippy J, Feiss M, et al. (2010) Decision making at a subcellular level determines the outcome of bacteriophage infection. Cell 141: 682-691.
23. Sussman R, Jacob F, (1962) Sur un système de répression thermosensible chez le bacteriophage lambda d'Escherichia coli. Comp. Rend 254: 1517-1519.
24. Refardt D, Rainey PB, (2010) Tuning a genetic switch: experimental evolution and natural variation of prophage induction. Evolution 64: 1086-1097.25.
25. Bailone A, Devoret R, (1978) Isolation of ultra-virulent mutants of phage lambda. Virology 84: 547-550.
26. Northrop JH, (1968) Appearance of virulent bacteriophages in lysogenic e. coli cultures after prolonged growth in the presence of triethylenemelamine. J Gen Physiol 52: 136-143.
27. Berngruber TW, Weissing FJ, Gandon S, (2010) Inhibition of superinfection and the evolution of viral latency. J Virol 84: 10200-10208.
28. Clément JM, Lepouce E, Marchal C, Hofnung M, (1983) Genetic study of a membrane protein: DNA sequence alterations due to 17 lamB point mutations affecting adsorption of phage lambda. EMBO J 2: 77-80.
29. Meyer JR, Dobias DT, Weitz JS, Barrick JE, Quick RT, et al. (2012) Repeatability and Contingency in the Evolution of a Key Innovation in Phage Lambda. Science 335: 428-432.
30. Kourilsky P, (1973) Lysogenization by bacteriophage lambda. I. Multiple infection and the lysogenic response. Mol. Gen. Genet 122: 183-195.
31. Avlund M, Dodd IB, Semsey S, Sneppen K, Krishna S, (2009) Why do phage play dice?. J Virol pp. 83.
32. Joh RI, Weitz JS, (2011) To lyse or not to lyse: transient-mediated stochastic fate determination in cells infected by bacteriophages. PLoS Comput. Biol 7: e1002006.
33. Bull JJ, Pfennig DW, Wang IN, (2004) Genetic details, optimization and phage life histories. Trends Ecol Evol 19: 76-82.
34. Bull JJ, (2006) Optimality models of phage life history and parallels in disease evolution. J Theor Biol 241: 928-938.
35. Mador N, Panet A, Steiner I, (2002) The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. J Neurovirology 8: 97-102.
36. Nethe M, Berkhout B, van der Kuyl AC, (2005) Retroviral superinfection resistance. Retrovirology 2: 52.
37. Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, et al. (2004) Unifying the Epidemiological and Evolutionary Dynamics of Pathogens. Science 303: 327-332.
38. Nowak MA, May RM, (1994) Superinfection and the evolution of parasite virulence. Proc R Soc. Lond B 255: 81-89.
39. van Baalen M, Sabelis MW, (1995) The dynamics of multiple infection and the evolution of virulence. Am Nat 146: 881-910.
40. de Roode JC, Pansini R, CheesmanSJ, Helsinki MEH, Huijben S, et al. (2005) Virulence and competitive ability in genetically diverse malaria infections. Proc Natl Acad Sci USA 102: 7624-7628.
41. Arien KK, Vanham G, Arts EJ, (2007) Is HIV-1 evolving to a less virulent form in humans? Nat Rev Micro 5: 141-151.
42. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, et al. (2005) Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression. J Virol 79: 9006-9018.
43. Adiwijaya BS, Kieffer TL, Henshaw J, Eisenhauer K, Kimko H, et al. (2012) A viral dynamic model for treatment regimens with directacting antivirals for Chronic Hepatitis C Infection. PLoS Comput Biol 8: e1002339.
44. Read AF, Day T, Huijben S, (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci USA 108: 10871-10877.
45. Alizon S, Luciani F, Regoes RR, (2011) Epidemiological and clinical consequences of within-host evolution. Trends Microbiol 19: 24-32.